References
- Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951;51:2399–402.
- Brittingham TE, Chaplin H Jr. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 1957;165:819–25.
- Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–7.
- Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266–73.
- Silliman CC, Boshkov L, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454–62.
- Bux J, Sachs U. The pathogenesis of transfusion-related acute lung injury. Br J Hematol 2007;136:788–99.
- Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774–89.
- Church GD, Price C, Sanchez R, Looney MR. Transfusion-related acute lung injury in the pediatric patient: two case reports and a review of the literature. Transfus Med 2006;16:343–8.
- Skeate RC, Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 2007;14:682–7.
- Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006;34(5 Suppl):S109–13.
- Tobian AA, Sokoll LJ, Tisch DJ, Ness PM, Shan H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008;48:1143–50.
- Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009;49:13–20.
- Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968–71.
- Clifford L, Singh A, Wislon GA, et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 2013;53: 1205–16.
- Eder A, Herron R, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006–2008). Transfusion 2010;50:1732–42.
- Eder A, Dy B, Perez J, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008–2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013;53: 1442–9.
- Arinsburg S, Skerrett D, Karp J, et al. Conversion to low transfusion-related acute lung injury-risk plasma significantly reduces TRALI. Transfusion 2012;52:946–52.
- U.S. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2013. Available at: http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/ucm391574.htm.
- Kleinman S, Grossman B, Kopko P. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010;50:1312–21.
- Process control standard 5.4.1.2. Standards for blood banks and transfusion services. 29th ed. Arlington, VA: American Association of Blood Banks, 2014:17.
- Popovsky MA, Haley NR. Further characterization of transfusion related acute lung injury: demographics, clinical and laboratory features and morbidity. Immunohematology 2000;16:157–9.